Results 211 to 218 of about 153,411 (218)

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

New England Journal of Medicine, 2012
Erwin W Gelfand
exaly  

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

New England Journal of Medicine, 2008
Ashley A Vo, Mieko Toyoda
exaly  

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

Lancet Diabetes and Endocrinology,the, 2013
Steven M Willi, Antoinette Moran
exaly  

Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation

New England Journal of Medicine, 2006
Daniel C Brennan
exaly  

Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia

New England Journal of Medicine, 2011
Phillip Scheinberg, Colin O Wu
exaly  

Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial

Lancet Oncology, The, 2017
Franco Locatelli, Carla Rognoni, Patrizia Comoli   +2 more
exaly  

FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin

Immunity, 2007
Kyung Hyung Park-Min, Gerald Krystal, Stephen L. Nutt   +2 more
exaly  

Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin

New England Journal of Medicine, 2001
exaly